At least six different proteins of the spliceosome, including PRPF3, PRPF4, PRPF6, PRPF8, PRPF31 19 and SNRNP200, are mutated in autosomal dominant retinitis pigmentosa (adRP). These proteins 20 have recently been shown to localise to the base of the connecting cilium of the retinal photoreceptor 21 cells, elucidating this form of RP as a retinal ciliopathy. In the case of loss-of-function variants in 22 these genes, pathogenicity can easily be ascribed. In the case of missense variants, this is more 23 challenging. Furthermore, the exact molecular mechanism of disease in this form of RP remains 24 poorly understood. 25
1
Introduction 36
Retinitis pigmentosa (RP) is a progressive retinal degeneration characterised by night blindness and 37 restriction of peripheral vision. Later in the course of the disease, central and colour vision can be 38 lost. Many patients experience the first signs of RP between 20-40 years but there is much 39 phenotypic variability from age of onset and speed of deterioration to severity of visual impairment 40 (Hartong et al., 2006) . 41 RP, whilst classified as a rare disease, is the most common cause of inherited blindness worldwide. It 42 affects between 1:3500 and 1:2000 people (Golovleva et al., 2010; Sharon and Banin, 2015) , and can 43 be inherited in an autosomal dominant (adRP), autosomal recessive (arRP), or X-linked (xlRP) 44 manner. It may occur in isolation (non-syndromic RP) (Verbakel et al., 2018) , or with other features 45 (syndromic RP) as in Bardet-Biedl syndrome, Joubert syndrome and Usher syndrome (Mockel et al., 46 2011). 47 The condition is extremely heterogeneous, with 64 genes identified as causes of non-syndromic RP, 48 and more than 50 genes associated with syndromic RP (RetNet https://sph.uth.edu/retnet/sum-49 dis.htm). Even with current genetic knowledge, diagnostic detection rate in adRP cohorts remains 50 between 40% (Mockel et al., 2011) and 66% (Zhang et al., 2016) , suggesting that many disease 51 genes remain to be identified, and many mutations within known genes require characterization to 52 ascribe pathogenic status. Detection rates are as low as 14% in cohorts of simplex cases (single 53 affected individuals) and multiplex cases (several affected individuals in one family but unclear 54 pattern of inheritance) (Jin et al., 2008) . Such cases account for up to 50% of RP cases, so this presents a significant challenge to diagnosis (Greenberg et al., 1993; Haim, 1993; Najera et al., 56 1995) . 57
The second most common genetic cause of adRP is PRPF31, accounting for 6% of US cases 58 (Sullivan et al., 2013) 8% of Spanish cases (Martin-Merida et al., 2018), 8% of French Canadian 59 cases (Coussa et al., 2015) , 8% of French cases (Audo et al., 2010) , 8.9% of cases in North America 60 (Daiger et al., 2014) , 11.1% in small Chinese cohort (Lim et al., 2009 ), 10% in a larger Chinese 61 cohort (Xu et al., 2012) and 10.5% of Belgian cases (Van Cauwenbergh et al., 2017) . However, this 62 is likely to be an underestimate due to variable penetrance of this form of RP, complicating attempts 63 to co-segregate the variant with clinical disease, making genetic diagnosis difficult. 64
Whilst the majority of reported variants in PRPF31 are indels, splice site variants and nonsense 65 variants, large-scale deletions or copy number variations (Martin-Merida et al., 2018) , which are 66 easily ascribed pathogenic status, at least eleven missense variants in PRPF31 have been reported in 67 the literature (Table 1) . Missense variants are more difficult to characterize functionally than 68 nonsense or splicing mutations (Cooper and Shendure, 2011) and it is likely that there are false 69 negative diagnoses in patients carrying missense mutations due to lack of confidence in prediction of 70 pathogenicity of such variants. This is reflected in the enrichment of PRPF31 missense variants 71 labelled 'uncertain significance' in ClinVar, a public repository for clinically-relevant genetic 72 variants (Landrum et al., 2016; Landrum et al., 2014) . Furthermore, work has shown that some 73 variants annotated as missense PRPF31 variants may in fact be affecting splicing of PRPF31, 74 introducing premature stop codons leading to nonsense mediated decay (NMD), a common disease 75 mechanism in RP11 (Rio Frio et al., 2008). One example is c.319C>G, which, whilst originally 76 annotated as p.Leu107Val, actually affects splicing rather than an amino acid substitution (Rio Frio et 77 al., 2008) . The presence of exonic splice enhancers is often overlooked by genetics researchers. 78 This is a provisional file, not the final typeset article 2006). Pre-mRNA splicing factors may have additional roles beyond splicing in the nucleus, after a 87 study recently found that PRPF6, PRPF8 and PRPF31 are all localized to the base of the retinal 88 photoreceptor connecting cilium and are essential for ciliogenesis, suggesting that this form of RP is 89 a ciliopathy (Wheway et al., 2015) . Missense variants in these proteins are, collectively, a common 90 cause of adRP. This presents significant challenges in providing accurate diagnosis for patients with 91 missense variants in these genes. Developing tools to provide accurate genetic diagnoses in these 92 cases is a significant clinical priority. 93
The most commonly used in silico predictors of pathogenicity of missense variants, PolyPhen2 94 (Adzhubei et al., 2010) and CADD (Kircher et al., 2014) , which use combined sequence 95 conservation, structural and machine learning techniques only have around 15 -20% success rate in 96 predicting truly pathogenic variants (Miosge et al., 2015) . Use of simple tools has around the same 97 success rate (Gnad et al., 2013) , and use of several tools in combination increases reliability 98 (Gonzalez-Perez and Lopez-Bigas, 2011). Insight from structural biologists and molecular cell 99 biologists is essential to make accurate predictions. 100
In this study we take advantage of the recently elucidated structure of the in-tact spliceosome to 101 model the effect of a novel variant in PRPF31, found in a patient attending the genetics eye clinic at 102 Bristol Eye Hospital. We combine this in silico analysis with in vitro studies to characterize this 103 novel variant. We show that analysis of protein complexes in silico can complement clinical and 104 laboratory studies in predicting pathogenicity of novel genetic variants. 105
Methods 106
Genetic testing 107
The study was conducted in accordance with the Declaration of Helsinki. Informed consent for 108 diagnostic testing was obtained from the proband in clinic. Genomic DNA was extracted from a 109 peripheral blood sample by Bristol Genetics Laboratory and tested against the retinal dystrophy panel 110 of 176 genes in the NHS accredited Genomic Diagnostics Laboratory at Manchester Centre for 111 Genomic Medicine, UK. 112
Splicing analysis 113
We used Human Splicing Finder (Desmet et al., 2009 ) to identify and predict the effect of variants on 114 splicing motifs, including the acceptor and donor splice sites, branch point and auxiliary sequences known to enhance or repress splicing. This programme uses 12 different algorithms to make a 116 comprehensive prediction of the effect of variants on splicing. 117 3D structural protein analysis 118 PyMol (Schrodinger Ltd) programme was used to characterize the effect of missense variants in 119 human PRPF31 protein. Missense variants were modelled on PRPF31 in the pre-catalytic 120 spliceosome primed for activation (PDB file 5O9Z) (Bertram et al., 2017) . 121
Variant construct cloning 122
Full-length, sequence-validated PRPF31 ORF clone with C-terminal myc tag was obtained from 123
Origene. c.341T>A variant was introduced using NEB Q5 site-directed mutagenesis kit. The entire 124 wild-type and mutant clone sequence was verified by Sanger sequencing (Source Bioscience). 125
Cell culture 126 HEK293 cells were cultured in DMEM high glucose + 10% FCS at 37°C, 5% CO 2 , and split at a 127 ratio of 1:8 once per week. hTERT-RPE1 cells (ATCC CRL-4000) were cultured in DMEM/F12 128 (50:50 mix) + 10% FCS at 37°C, 5% CO 2 , and split at a ratio of 1:8 once per week. 129
Cell transfection 130
The construct was transfected into HEK293 cells using PEI, and into hTERT-RPE1 cells using the 131 Lonza Nucleofector. 132
Inhibition of protein translation 133
Cells were grown for 72 hours, and treated with 30µg/ml cycloheximide in DMSO. Untreated cells 134 were treated with the equivalent volume of DMSO. 135
Protein extraction 136
Total protein was extracted from cells using 1% NP40 lysis buffer and scraping. Insoluble material 137 was pelleted by centrifugation at 10,000 x g. Cell fractionation was carried out by scraping cells into 138 fractionation buffer containing 1mM DTT, and passed through a syringe 10 times. Nuclei were 139 pelleted at 720 x g for 5 minutes and separated from the cytoplasmic supernatant. Insoluble 140 cytoplasmic material was pelleted using centrifugation at 10,000 x g for 5 minutes. Nuclei were This is a provisional file, not the final typeset article washed, and lysed with 0.1% SDS and sonication. Insoluble nuclear material was pelleted using 142 centrifugation at 10,000 x g for 5 minutes. 143
SDS-PAGE and western blotting 144
20µg of total protein per sample with 2 x SDS loading buffer was loaded onto pre-cast 4-12% Bis-145
Tris gels (Life Technologies) alongside Spectra Multicolor Broad range Protein ladder (Thermo 146 Fisher). Samples were separated by electrophoresis. Protein was transferred to PVDF membrane. 147
Membranes were incubated with blocking solution (5% (w/v) non-fat milk/PBS), and incubated with 148 primary antibody overnight at 4 o C. After washing, membranes were incubated with secondary 149 antibody for 1 hour at room temperature and exposed using 680nm and/or 780nm laser, or incubated 150 with SuperSignal West Femto reagent (Pierce) and exposed using Chemiluminescence settings on 151 LiCor Odyssey imaging system (LiCor). in any individuals within the gnomAD database, nor are any other variants affecting Ile114, 195 suggesting that this is a highly conserved residue. Analysis by PolyPhen2 suggested this change was 196 probably damaging, with a score of 0.963 (Figure 1c ) and SIFT concurred with this prediction with a This is a provisional file, not the final typeset article score of 0.0. Comparative genomic alignment shows the residue to be conserved from humans to 198 amphibia, within a highly conserved region, conserved across diverse metazoa including sponges 199 (Figure 1c) . 200
Splicing analysis of genetic single nucleotide variants in PRPF31 201
We undertook in silico splicing analysis of our novel variant of interest c.341T>A p. Ile114Asn and 202 found that it was not predicted to affect splicing. We also studied the nine published variants in 203 PRPF31 annotated as missense, and interestingly, five were predicted to potentially alter splicing, 204 and one (c.1373A>T, p. Gln458Leu (Xiao et al., 2017) ) was predicted to be highly likely to affect 205 splicing ( Table 2) . This suggests that either this splice predictor should be used with caution, or that 206 p.Gln458Leu may be mis-annotated as a missense variant, when it actually affects splicing. We 207 suggest that this variant should be a priority for further functional characterization in vitro. 208
3D structural analysis of missense variants in PRPF31 209
We mapped all published missense variants onto the PRPF31 protein structure in the pre-catalytic electrostatic interactions and can be predicted to be affecting protein folding and solubility (Jeffrey 224 1997) . In the case of Arg408Trp, the substitution does not affect H bonding within PRPF31, but does 225 introduce a new interaction with neighbouring PRPF6 (Figure 3a; Supplementary Figures 1 and Supplementary Figure 2) . Of the three small substitutions which do not affect H bonding, we 228 discovered that in all cases the variant amino acid was proline, which introduces a new kink in the 229 amino acid chain. Each of these substitutions also resulted in the loss of a polar contact ( Figure  230 3c,d,e). 231
We next mapped the variant found in our patient attending the genetics eye clinic at Bristol Eye 232
Hospital; Ile114Asn (Figure 4a) . Ile114Asn is in the coiled-coil domain of the protein, in close 233 proximity to published pathogenic variants Thr138Lys and Ala194Glu (Figure 4b) . The substitution 234
introduces new H bonds between this residue and Ala190 of an adjacent α -helix, and predict it to 235 affect protein folding and solubility, and be pathogenic. 236
To test the accuracy of our predictions, we took on c.341T>A p.Ile114Asn for further in vitro 237 characterisation. 238
In vitro analysis of c.341T>A p.Ile114Asn variant 239
To investigate whether c.341T>A p.Ile114Asn caused mislocalisation of the protein, we transfected 240 RPE1 cells with plasmids expressing either wild-type (WT) PRPF31 or PRPF31 341T>A, both 241 tagged with c-myc epitope tag. We used the Lonza nucleofector to ensure high transfection efficiency 242 (~75%). We assayed the cells after 24, 48 and 72 hours by immunofluorescence confocal microscopy 243 using an anti-cmyc antibody and saw consistent mid-to high-level expression of the WT protein 244 exclusively in the nucleus (Figure 5a) . We did not observe the same pattern in cells expressing the 245 mutant protein. In these cells, intense c-myc staining was seen in the nuclei of a subset of cells, and 246 no cells showed normal nuclear expression levels (Figure 5a) . After 72 hours, many cells in the 247 mutant experiment had died, or showed abnormal nuclear morphology (Figure 5b) . We hypothesised 248 that the mutant protein was aggregating in the nuclei and causing cell death. 249
In order to investigate whether c.341T>A p.Ile114Asn affected protein stability in a similar way, we 250 transfected HEK293 cells with plasmids expressing either wild-type PRPF31 or PRPF31 341T>A, 251 both tagged with c-myc epitope tag. We treated the transfected cells with cycloheximide protein 252 translation inhibitor over a time course of 6 hours, and assayed protein concentration over this period 253 via western blotting. 254
Following our usual method for total protein extraction from cells using 1% NP40 detergent, we had 255 difficulty extracting any mutant protein from the transfected cells (Figure 6a) . This was despite the This is a provisional file, not the final typeset article fact that we could observe protein expression in both cell types via immunofluorescent staining with 257 anti-PRPF31 and anti-cmyc antibodies. We proceeded to repeat the experiment using cell 258 fractionation, to selectively extract protein from the nuclear fraction using 0.1% SDS. This yielded a 259 small amount of mutant protein (Figure 6b) . Based on our observations, we hypothesised that the 260 mutant protein was in the insoluble nuclear fraction. Once again, we fractionated the cells and lysed 261 the nuclei with 0.1% SDS, but this time we did not remove the insoluble material by centrifugation, 262 instead loading both soluble and insoluble nuclear protein on the gel. This revealed mutant protein, 263 and confirms that the mutant protein is expressed in cells, but is insoluble (Figure 6c) . No difference 264 in protein stability was observable in the course of cycloheximide treatment (Figure 6c) . Once we 265 had optimised protein extraction from these cells, we were able to confirm our finding from 266 immunofluorescent imaging that both the WT and mutant protein localised to the nucleus, not the 267 cytoplasm (Figure 6d) . 268
In summary, our findings suggest that c. domain, coiled-coil domain and tip. The flexible loop (residues 256 -265) protects the exposed C4' atoms of residues 37 and 38 from attack by free radicals, to protect the RNA without directly 287 contacting it (Liu et al., 2007) . 288
The Nop domain is a conserved RNP-binding domain, with regions for binding protein and RNA. 289
Although the sequence conservation of the Nop domain is relaxed in PRPF31, its specificity for 290 binding U4 or U4atac and 15.5K protein is high (Liu et al., 2007) . Nop and coiled-coil domains and in silico analysis predicts that this missense mutation does not 304 affect H bonding within PRPF31. Based on this analysis, it may be predicted that this change is 305 unlikely to be pathogenic, but 3D analysis of the intact spliceosome predicts that this changes affects 306 binding of PRPF31 to PRPF6 (Figure 3a) . We would predict that this change is pathogenic, and that 307 missense variants outside the Nop and coiled-coil domains should not be dismissed as benign. 308
Using this 3D protein complex analysis, we predict a novel variant, Ile114Asn, found in a patient 309 attending the genetics eye clinic at Bristol Eye Hospital, to be affecting H bonding within PRPF31 310 and predict that this will affect protein folding and solubility (Figure 4a-c) . Our in vitro studies 311 confirm this (Figures 5, 6) . Protein with this variant is found in the insoluble nuclear fraction, and 312 this leads to cell death (Figures 5, 6) . 313
In summary, we show that in silico modelling of the effect of missense variants on the 3D structure 314 of the spliceosome contributes useful additional data to predictions of pathogenicity of novel 315 variants. which are likely to affect protein folding and solubility. In the novel variant studied here, This is a provisional file, not the final typeset article the predictions from this in silico structural analysis were confirmed using in vitro testing. It is 317 important to note that the spliceosome is a highly dynamic structure, and our 3D structural complex 318 analysis only studies PRPF31 in one specific conformation, in the spliceosome primed for splicing 319 (Bertram et al., 2017) . For truly accurate predictions of pathogenicity, the 3D structure of the 320 spliceosome at different stages of activity will need to be studied, preferably using Molecular 321 dynamic simulation (MDS) with a package such as GROMACS (Berendsen et al., 1995) U4 snRNA (orange backbone), with published missense mutations mapped onto the physical 366 structure, with wild-type amino acid structure in green, and mutant amino acid structure overlaid in 367 red. Ile114Asn (black arrow) is mapped onto the structure with wild-type amino acid structure in 368 green, and mutant amino acid structure overlaid in blue. 
